Toll-like receptor 4–dependent contribution of the immune system to anticancer chemotherapy and radiotherapy

Keywords

Immunogenic cell deathImmunoadjuvantRadiation therapyImmune systemCancer researchToll-like receptorHMGB1Acquired immune systemTLR4ImmunotherapyImmunologyChemotherapyMedicineDendritic cellCancerBiologyInnate immune systemInternal medicineInflammation

Affiliated Institutions

Related Publications

The interaction between HMGB1 and TLR4 dictates the outcome of anticancer chemotherapy and radiotherapy

Lionel Apétoh , François Ghiringhelli , Antoine Tesnière +11 more

Summary: For the last four decades, the treatment of cancer has relied on four treatment modalities, namely surgery, radiotherapy, cytotoxic chemotherapy, and hormonotherapy. Mo...

2007 Immunological Reviews 545 citations

Selective Roles for Toll-Like Receptor (TLR)2 and TLR4 in the Regulation of Neutrophil Activation and Life Span

Ian Sabroe , Lynne R. Prince , Elizabeth C. Jones +5 more

Abstract Neutrophil responses to commercial LPS, a dual Toll-like receptor (TLR)2 and TLR4 activator, are regulated by TLR expression, but are amplified by contaminating monocyt...

2003 The Journal of Immunology 339 citations

Cancer immunotherapy using checkpoint blockade

Antoni Ribas , Jedd D. Wolchok

The release of negative regulators of immune activation (immune checkpoints) that limit antitumor responses has resulted in unprecedented rates of long-lasting tumor responses i...

2018 Science 6236 citations

Toll-Like Receptor Triggering of a Vitamin D-Mediated Human Antimicrobial Response

Philip T. Liu , Steffen Stenger , Huiying Li +19 more

In innate immune responses, activation of Toll-like receptors (TLRs) triggers direct antimicrobial activity against intracellular bacteria, which in murine, but not human, monoc...

2006 Science 3843 citations

Immune Regulation of Cancer

Mary L. Disis

Innate and adaptive immune system cells play a major role in regulating the growth of cancer. Although it is commonly thought that an immune response localized to the tumor will...

2010 Journal of Clinical Oncology 480 citations

Publication Info

Year: 2007
Type: article
Volume: 13
Issue: 9
Pages: 1050-1059
Citations: 2901
Access: Closed

External Links

View on DOI.org

Social Impact

Altmetric

Toll-like receptor 4–dependent contribution of the immune system to anticancer chemotherapy and radiotherapy

PlumX Metrics

Social media, news, blog, policy document mentions

Citation Metrics

2901

OpenAlex

Cite This

APA Style

                            
                                
                                    Lionel Apétoh, 
                                
                                    François Ghiringhelli, 
                                
                                    Antoine Tesnière
                                
                                et al.
                            
                            (2007). 
                            Toll-like receptor 4–dependent contribution of the immune system to anticancer chemotherapy and radiotherapy. 
                            Nature Medicine
                            , 13
                            (9)
                            , 1050-1059.
                            https://doi.org/10.1038/nm1622
                        

Identifiers

DOI: 10.1038/nm1622